Scientists hunt for clues to predict prostate cancer treatment success
NCT ID NCT05477823
Summary
This small, early-stage study aims to find clues that can predict how well a patient's high-risk prostate cancer will respond to standard treatment. Researchers will look at special medical scans and a genetic test from 30 men already scheduled to receive radiation and hormone therapy. The goal is to learn if these clues can identify, early on, which patients are at risk for a poor response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.